CJC-1295 No DAC & Ipamorelin Side Effects in Studies
CJC-1295 No DAC & Ipamorelin Side Effects in Studies A 2012 Phase II trial examining growth hormone secretagogues found that the most common adverse events weren't systemic toxicity or endocrine disruption. They were lo…
Read article